MoonLake Stock (NASDAQ: MLTX) stock price, news, charts, stock research, profile.
You can purchase shares of MoonLake (NASDAQ:MLTX) through any online brokerage.
Other companies in MoonLake’s space includes: Immunovant (NASDAQ:IMVT), Twist Bioscience (NASDAQ:TWST), Ultragenyx Pharmaceutical (NASDAQ:RARE), Avidity Biosciences (NASDAQ:RNA) and SpringWorks Therapeutics (NASDAQ:SWTX).
MoonLake has a consensus price target of $64.54.
The stock price for MoonLake (NASDAQ: MLTX) is $52.14 last updated December 23, 2024 at 4:00 PM EST.
There are no upcoming dividends for MoonLake.
MoonLake’s Q4 earnings are confirmed for Thursday, February 27, 2025.
There is no upcoming split for MoonLake.
MoonLake is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.